Hyundai Bioscience

HYUNDAI BIOSCIENCE is a biotechnology company that develops and commercializes bio-fusion technologies aimed at delivering active ingredients safely and effectively to the body. By utilizing innovative vitamin C stabilization technology, HYUNDAI BIOSCIENCE has expanded its business scope to skincare and cosmetics. HYUNDAI BIOSCIENCE has developed Vitabrid CG, a new biomaterial that combines vitamin C with bio-friendly mineral layers, serving as a beneficial component for skin whitening, anti-aging, and anti-inflammatory purposes. The company’s CP-COV03 is a broad-spectrum antiviral treatment capable of addressing various viruses, including the coronavirus. The company has recruited confirmed COVID-19 patients to participate in dosing trials and has entered Phase II clinical trials for CP-COV03, an oral antiviral candidate.